Physician profile
Carson Sanders
NPI 1699035378
$7,098.91
in general payments reported to CMS, 2019-2025
12 companies · $268 in 2025
The $268 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,335 · 2020: $878 · 2021: $83.78 · 2022: $146 · 2023: $189 · 2024: $200 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,811.98 | 2019 | |
| Peerless Surgical INC. | $1,484.71 | 2019-2025 | |
| Exactech, INC. | $987.67 | 2019-2023 | |
| Linvatec Corporation | $908.92 | 2019 | |
| Stryker Corporation | $536.05 | 2019-2025 | Mako, Triathlon, Insignia |
| Acumed LLC | $145.72 | 2022 | |
| Pacira Therapeutics, INC. | $127.63 | 2019-2020 | |
| Boston Scientific Corporation | $27.34 | 2023 | Wavewriter Alpha Prime 16 |
| Axogen | $18.64 | 2020 | |
| Zimmer Biomet Holdings, INC. | $17.50 | 2021 | |
| Ethicon US, LLC | $16.78 | 2025 | Vistaseal |
| Medtronic USA, INC. | $15.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carson Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.